Skip to content

Oral Protein Supplementation Following Non-bariatric Surgery

A Randomized Trial of Oral Protein Supplementation Following Non-bariatric Abdominal Surgery

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02622698
Enrollment
62
Registered
2015-12-04
Start date
2011-08-31
Completion date
2012-06-30
Last updated
2015-12-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Protein Supplementation

Brief summary

Investigators performed a randomized controlled trial of 62 patients undergoing elective abdominal operations. The treatment group was provided a liquid protein supplement and instructed to take a dose three times daily for the first 20 postoperative days. Investigators followed patients for six months and compared wound healing and changes in weight and laboratory values.

Interventions

DIETARY_SUPPLEMENTProstat AWC

Prostat AWC- patients received protein supplementation after surgery

OTHERPlacebo

Placebo- Patients did not take any protein supplementation after surgery

Sponsors

Medical Nutrition USA, Inc.
CollaboratorINDUSTRY
Eisenhower Army Medical Center
Lead SponsorFED

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* patients scheduled to undergo abdominal surgery \[cholecystectomy, ventral hernia repair, colectomy, non-bariatric gastric surgery, appendectomy, small bowel resection, lysis of adhesions, liver resection, splenectomy, proctectomy, stoma construction, pancreatic surgery, duodenal surgery, adrenal surgery, renal surgery, or cystectomy\]

Exclusion criteria

* Age less than 18 years * Pregnant * Abdominal surgery within the past 6 months * Inability to attend follow-up appointments for at least 6 months * Liver failure (Child-Pugh Class B or C) or kidney failure (glomerular filtration rate (GFR) less than 30).

Design outcomes

Primary

MeasureTime frameDescription
Change in weightPreoperative, and then postoperative at 1-2 weeks, 3 weeks, 1 month, 2 months, 3 months, 6 monthsMean preoperative weight compared to mean postoperative weight at each follow-up appointment. Weight recorded in pounds, subsequent measurements at each postoperative point were normalized to the preoperative weight and reported as a relative percentage of the preoperative weight.

Secondary

MeasureTime frameDescription
Wound healingPreoperative, and then postoperative at 1-2 weeks, 3 weeks, 1 month, 2 months, 3 months, 6 monthsOverall wound healing was documented on a scale of 0-2 (0 for unhealed, 1 for partially healed, 2 for completely healed). A wound was considered partially healed if there was any portion of the wound which had epidermal edges that were not in direct contact.
Change in white blood cell count (1x10 3/ uL)Preoperative, and then postoperative at 1-2 weeks, 3 weeks, 1 month, 2 months, 3 months, 6 monthsChange in white blood cell count relative to preoperative white blood cell count, calculated as absolute change
Change in total protein (g/ dL)Preoperative, and then postoperative at 1-2 weeks, 3 weeks, 1 month, 2 months, 3 months, 6 monthsChange in total protein at each follow-up point relative to preoperative total protein, calculated as absolute change
Change in albumin (g/ dL)Preoperative, and then postoperative at 1-2 weeks, 3 weeks, 1 month, 2 months, 3 months, 6 monthsChange in albumin at each follow-up point relative to preoperative albumin, calculated as absolute change
Change in prealbumin (mg/ dL)Preoperative, and then postoperative at 1-2 weeks, 3 weeks, 1 month, 2 months, 3 months, 6 monthsChange in prealbumin at each follow-up point relative to preoperative prealbumin, calculated as absolute change

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026